From GlobeNewswire: 2024-04-02 11:30:00

The global genotyping assay market has seen significant growth, reaching $27.7 billion in 2023 and projected to hit $33.98 billion in 2024, with a CAGR of 22.7%. By 2028, it is estimated to rise to $77.77 billion at a CAGR of 23.0%, driven by customization, personalization trends, and advancements in genomic research.

Key factors influencing the genotyping assay market’s expansion include customization trends, health movements, e-commerce growth, and the demand for personalized medicine. As personalized medicine gains traction, tailored medical treatments based on genetic profiles are becoming more prevalent, enhancing healthcare interventions and drug selection.

Technological advancements and strategic partnerships play a crucial role in the genotyping assay market. Innovations like CE-IVD marked assays for detecting HIV-1 strains show a commitment to enhancing diagnostics. Companies like Thermo Fisher Scientific are introducing advanced kits to detect treatment-resistant strains of HIV-1, while strategic acquisitions aim to broaden service offerings.

Market segmentation based on product and service, technology, and end-users provides a comprehensive view of the genotyping assay market, allowing stakeholders to tailor strategies and capitalize on emerging opportunities. With increasing demand for personalized medicine and technological advancements, the market is poised for exponential growth, presenting lucrative prospects for industry players.

The Business Research Company offers detailed insights into the genotyping assay market, including size, segments, trends, competitors’ positioning, revenues, and market shares. By leveraging this information, healthcare providers, pharmaceutical firms, researchers, and policymakers can make informed decisions regarding investments, product development, and partnerships, contributing to the advancement of personalized medicine and genomic research.



Read more at GlobeNewswire: Exponential Growth Predicted For Genotyping Assay Market: